Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 32341-32350 Newer>

The Motley Fool September 30, 2008 Brian Lawler	Moody's Gets Moody With Drugmakers European pharmaceuticals get a negative rating from Moody's.
The Motley Fool September 30, 2008 Toby Shute	Are Energy Deals Doomed? That all depends on who's buying.
The Motley Fool September 30, 2008 Anders Bylund	Chrome Mission: Accomplished! Google's new Chrome browser has already done everything it was meant to do.
The Motley Fool September 30, 2008 Brian Lawler	Novo Nordisk Takes On All Comers Its diabetes franchise is about to get bigger.
The Motley Fool September 30, 2008 Tim Beyers	First, Let's Kill All the Short-Sellers New rules seem destined to stick it to the shorts.
The Motley Fool September 30, 2008 Tim Beyers	Should You Buy Apple? Analyst downgrades have Fools wondering.
The Motley Fool September 30, 2008 Brian Lawler	No Approval for You ... Yet The FDA makes Eli Lilly wait for word on a lead drug.
The Motley Fool September 30, 2008 Tim Beyers	What This Meltdown Means for Tech Investors It may not be as bad as you think. Technology companies that get a lot of revenue from outside that U.S. may have good prospects.
The Motley Fool September 30, 2008 Brian Orelli	Pharma, Cash, and You Pharma's been saving for a rainy day, and there's a thunderstorm outside.
The Motley Fool September 30, 2008 Brian Orelli	Cardinal Health Clips Its Wings Does it make sense for the drug wholesaler to spin off its medical equipment business?
<Older 32341-32350 Newer> Return to current articles.